Literature DB >> 17018900

Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer.

Vidya Vootukuru1, Yin Ping Liew, Joseph V Nally.   

Abstract

We report a patient with metastatic non-small cell lung cancer who developed renal toxicities manifest as acute renal failure associated with nephrogenic diabetes insipidus and distal renal tubular acidosis following sequential therapy with pemetrexed. The nephrotoxicity occurred concomitantly with severe myelosuppression. We postulate renal tubular toxicity may account for distinct patterns of injury including acute renal failure and tubular cell dysfunction of the distal nephron.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018900     DOI: 10.1385/MO:23:3:419

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  3 in total

Review 1.  The evolving role of pemetrexed (Alimta) in lung cancer.

Authors:  Mark A Socinski; Thomas E Stinchcombe; D Neil Hayes
Journal:  Semin Oncol       Date:  2005-04       Impact factor: 4.929

2.  A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation.

Authors:  D A Rinaldi; J G Kuhn; H A Burris; F A Dorr; G Rodriguez; S G Eckhardt; S Jones; J R Woodworth; S Baker; C Langley; D Mascorro; T Abrahams; D D Von Hoff
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

Review 3.  FDA drug approval summaries: pemetrexed (Alimta).

Authors:  Maitreyee Hazarika; Robert M White; John R Johnson; Richard Pazdur
Journal:  Oncologist       Date:  2004
  3 in total
  10 in total

1.  Pemetrexed induced acute kidney injury in patients with non-small cell lung cancer: reversible and chronic renal damage.

Authors:  Giuseppe Rombolà; Franco Vaira; Matteo Trezzi; Nadia Chiappini; Valeria Falqui; Francesco Londrino
Journal:  J Nephrol       Date:  2014-07-02       Impact factor: 3.902

2.  Pemetrexed-Induced Nephrogenic Diabetes Insipidus.

Authors:  Enrica Fung; Shuchi Anand; Vivek Bhalla
Journal:  Am J Kidney Dis       Date:  2016-05-28       Impact factor: 8.860

3.  An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

Authors:  Yujia Wen; Eric R Gamazon; Wasim K Bleibel; Claudia Wing; Shuangli Mi; Bridget E McIlwee; Shannon M Delaney; Shiwei Duan; Hae Kyung Im; M Eileen Dolan
Journal:  Hum Mol Genet       Date:  2011-12-13       Impact factor: 6.150

4.  Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia.

Authors:  Benazir Abbasi; Amjad Hayat; Mark Lyons; Ananya Gupta; Sanjeev Gupta
Journal:  Heliyon       Date:  2022-07-12

Review 5.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12

6.  Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed.

Authors:  Maureen Assayag; Philippe Rouvier; Marion Gauthier; Ghania Costel; Philippe Cluzel; Lucile Mercadal; Gilbert Deray; Corinne Isnard Bagnis
Journal:  BMC Cancer       Date:  2017-11-16       Impact factor: 4.430

7.  Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature.

Authors:  Yassir Sbitti; Hafsa Chahdi; Khaoula Slimani; Adil Debbagh; Anouar Mokhlis; Abderrahmane Albouzidi; Fahd Bennani; Hassan Errihani; Mohamed Ichou
Journal:  J Med Case Rep       Date:  2017-07-28

8.  Pemetrexed-induced acute kidney failure following irreversible renal damage: two case reports and literature review.

Authors:  Tito Zattera; Francesco Londrino; Matteo Trezzi; Roberto Palumbo; Antonio Granata; Paola Tatangelo; Valentina Corbani; Valeria Falqui; Nadia Chiappini; Lisa Mathiasen; Marco Cavallini; Davide Rolla
Journal:  J Nephropathol       Date:  2016-10-27

9.  Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy.

Authors:  Judith Michels; Jean Philippe Spano; Isabelle Brocheriou; Gilbert Deray; David Khayat; Hassane Izzedine
Journal:  Case Rep Oncol       Date:  2009-03-14

10.  Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.

Authors:  Misa Naganuma; Yumi Motooka; Sayaka Sasaoka; Haruna Hatahira; Shiori Hasegawa; Akiho Fukuda; Satoshi Nakao; Kazuyo Shimada; Koseki Hirade; Takayuki Mori; Tomoaki Yoshimura; Takeshi Kato; Mitsuhiro Nakamura
Journal:  SAGE Open Med       Date:  2018-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.